Free Trial

FY2025 EPS Estimates for Canopy Growth Reduced by Analyst

Canopy Growth logo with Medical background

Canopy Growth Co. (NASDAQ:CGC - Free Report) - Roth Capital cut their FY2025 earnings per share (EPS) estimates for shares of Canopy Growth in a report issued on Wednesday, May 28th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings of ($1.96) per share for the year, down from their prior estimate of ($1.89). The consensus estimate for Canopy Growth's current full-year earnings is ($2.81) per share. Roth Capital also issued estimates for Canopy Growth's Q4 2025 earnings at ($0.12) EPS.

Separately, Piper Sandler reaffirmed an "underweight" rating on shares of Canopy Growth in a research note on Friday, May 30th.

Read Our Latest Stock Report on Canopy Growth

Canopy Growth Trading Up 5.4%

CGC stock traded up $0.07 during trading on Monday, hitting $1.37. The company had a trading volume of 7,506,682 shares, compared to its average volume of 5,917,205. The business has a 50-day moving average of $1.30 and a 200-day moving average of $1.96. The company has a current ratio of 3.52, a quick ratio of 2.58 and a debt-to-equity ratio of 0.74. Canopy Growth has a one year low of $0.77 and a one year high of $8.65. The stock has a market cap of $251.90 million, a PE ratio of -0.36 and a beta of 0.79.

Canopy Growth (NASDAQ:CGC - Get Free Report) last announced its earnings results on Friday, May 30th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.66). Canopy Growth had a negative net margin of 156.98% and a negative return on equity of 56.52%. The company had revenue of $45.30 million during the quarter, compared to the consensus estimate of $71.84 million.

Institutional Investors Weigh In On Canopy Growth

Institutional investors and hedge funds have recently made changes to their positions in the business. Jones Financial Companies Lllp boosted its position in shares of Canopy Growth by 222.9% during the 4th quarter. Jones Financial Companies Lllp now owns 9,315 shares of the company's stock valued at $26,000 after purchasing an additional 6,430 shares in the last quarter. Apollon Wealth Management LLC bought a new position in shares of Canopy Growth during the 4th quarter worth approximately $38,000. Dimensional Fund Advisors LP bought a new position in shares of Canopy Growth during the 4th quarter worth approximately $41,000. Mackenzie Financial Corp boosted its holdings in shares of Canopy Growth by 56.5% during the 1st quarter. Mackenzie Financial Corp now owns 50,413 shares of the company's stock worth $47,000 after buying an additional 18,202 shares in the last quarter. Finally, Concurrent Investment Advisors LLC boosted its stake in Canopy Growth by 26.6% during the fourth quarter. Concurrent Investment Advisors LLC now owns 24,644 shares of the company's stock worth $68,000 after acquiring an additional 5,172 shares in the last quarter. Institutional investors own 3.33% of the company's stock.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Recommended Stories

Earnings History and Estimates for Canopy Growth (NASDAQ:CGC)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines